Majestic American Journal of Oncology
The Majestic American Journal of Oncology (AJONCO) is an international, peer-reviewed, open-access journal dedicated to advancing high-quality research across the full spectrum of oncology. The journal aims to facilitate the rapid dissemination of impactful scientific knowledge that contributes to the prevention, early detection, diagnosis, treatment, and comprehensive management of cancer.
AJONCO serves as a global platform for clinicians, researchers, healthcare professionals and policymakers, promoting the translation of scientific discoveries into clinical practice and public health outcomes.
Aims
- Publish high-quality, original and evidence-based research in all areas of oncology.
- Promote translational and interdisciplinary research bridging laboratory discoveries and clinical applications.
- Support advancements in precision medicine, targeted therapies and immuno-oncology.
- Encourage research that improves patient outcomes, survivorship and quality of life.
- Foster global collaboration and knowledge exchange among oncology professionals.
- Contribute to the development of equitable and accessible cancer care systems worldwide.
- Serve as a global platform for clinicians, researchers, healthcare professionals, and policy makers, promoting the translation of scientific discoveries into clinical practice and public health outcomes.
Scope
AJONCO welcomes a wide range of contributions including original research articles, systematic reviews, meta-analyses, clinical studies, case reports, short communications and perspectives.
Core Areas of Oncology
- Basic and Translational Research: Tumor biology, cancer genomics, epigenetics, molecular signaling pathways, biomarkers and preclinical models.
- Clinical Oncology: Clinical trials, novel diagnostics, targeted therapies, immunotherapy (including checkpoint inhibitors, CAR-T cell therapy), radiotherapy, surgical oncology and precision medicine.
- Cancer Prevention and Epidemiology: Risk factors, screening strategies, early detection, cancer registries and population-based studies.
- Supportive and Palliative Care: Symptom management, survivorship, quality of life, rehabilitation and end-of-life care.
- Oncology Health Systems and Policy: Health economics, access to care, healthcare delivery models, cancer control programs and policy development.
Emerging and Advanced Areas
- Artificial intelligence and machine learning in oncology.
- Liquid biopsy and minimally invasive diagnostics.
- Personalized and precision oncology.
- Cancer immunology and tumor microenvironment.
- Digital health, tele-oncology and remote patient monitoring.
- Nanotechnology and drug delivery systems.
- Real-world evidence and big data in cancer research.
- Integrative and multidisciplinary oncology approaches.
Cancer-Specific Focus Areas
- Breast Cancer.
- Lung Cancer.
- Gastrointestinal Cancers.
- Skin Cancer and Melanoma.
- Head and Neck Cancer.
- Pediatric Oncology.
- Neuro-oncology.
- Genitourinary Cancers.
- Hematologic Malignancies.
- Soft Tissue and Bone Sarcomas.
Cross-cutting Areas
- Evidence-based oncology.
- Psycho-oncology.
- Cancer survivorship and rehabilitation.
- Ethical, social and behavioral aspects of cancer care.
Target Audience
AJONCO is intended for:
- Oncologists and clinical practitioners.
- Cancer researchers and scientists.
- Healthcare professionals and allied medical staff.
- Public health experts and epidemiologists.
- Policy makers and healthcare administrators.
- Academic institutions and research organizations.